Technology Industry

Industry: Email Alert RSS Feed

Biogen Building Second Plant

BT Catalyst, Dec, 1999

Biogen Inc. of Cambridge, Mass., has started construction of a 250,000-square-foot drug production plant at its Research Triangle Park campus.

The large-scale manufacturing plant, scheduled to open in late 2001 or early 2002, will manufacture new drug candidates that could be marketed commercially in as little as two to four years.

Biogen currently has a 100,000-square-foot plant in the park that employs 125 people involved in the manufacture of Avonex, the world's top selling multiple sclerosis drug. This plant cost $57 million to build in 1996.

Approximately 75 to 100 employees will be added to Biogen's payroll in the park when the new plant opens.

Most RecentTechnology Articles

Biogen has not yet disclosed the cost of the facility or the actual products that will be manufactured there. Lisa Easley, the company's spokesperson, said an official groundbreaking ceremony scheduled for the first quarter of the new year will provide these details.

COPYRIGHT 1999 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:
  1. You are currently: a Guest |
  4.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a>)

White Papers, Webcasts, and Resources

advertisement
CXO UnpluggedSmart Business interviews on BNET

See and hear how senior level executives across the Asia Pacific are developing smart business ideas across a variety of sectors. The focus is on the future, and on how businesses need to evolve.

Brought to you by CBS MoneyWatch.com

advertisement
advertisement

Content provided in partnership with Thompson Gale